BiomX (PHGE) Current Taxes (2018 - 2019)

BiomX (PHGE) posted Current Taxes of $87713.0 for Q3 2019, down 35.7% sequentially from $136419.0 in Q2 2019.

BiomX (PHGE) Current Taxes (2018 - 2019) Analysis & Trends

BiomX has reported Current Taxes for 2 years, with the latest figure at $87713.0 in Q3 2019.

Quarterly Current Taxes changed N/A year-over-year to $87713.0 in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $87713.0 (changed N/A YoY) and the FY2019 annual result came in at $136419.0, changed N/A from the prior year.
Current Taxes retreated to $87713.0 in Q3 2019 per PHGE's latest filing, from $136419.0 in the prior quarter.
Over five years, Current Taxes peaked at $136419.0 in Q2 2019 and troughed at $8212.0 in Q4 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	49.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	76.32 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	76.36 Mn
10	BiomX	361,408.40	-806,591.60	-	-

Download Data